Flare Therapeutics
Latest round
- Series C
Last raised
- Jul 2026
Total raised
- $290M
Investors
- 13
About Flare Therapeutics
Founded in 2021 and based in Massachusetts, US, Flare Therapeutics, Inc. is a biotechnology company that focuses on discovering medicines for cancer and other diseases. The firm was co-founded by Dr. Steven McKnight. In July 2026, Flare Therapeutics, Inc. Flare Therapeutics, Inc. deciphers the deoxyribonucleic acid (DNA) transcription factors to develop small molecule medicines in treating cancers and diseases. The firm provides drug discovery programs that address transcription factors focused on precision oncology.
Who invested in Flare Therapeutics
13 investors across 3 rounds
See all investors in Flare Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Flare Therapeutics
Who invested in Flare Therapeutics?
Flare Therapeutics has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Flare Therapeutics raised?
Flare Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Flare Therapeutics last raise money?
Flare Therapeutics's most recent round on record is a Series C, in Jul 2026.
What does Flare Therapeutics do?
Founded in 2021 and based in Massachusetts, US, Flare Therapeutics, Inc.
Where is Flare Therapeutics headquartered?
Flare Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Flare Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Flare Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Flare Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.